• 1
    Farries TC, Atkinson JP. Evolution of the complement system. Immunol Today 1991; 12: 295300.
  • 2
    Nonaka M. Evolution of the complement system. Curr Opin Immunol 2001; 13: 6973.
  • 3
    Mastellos D, Lambris JD. Complement: more than a ‘guard’ against invading pathogens? Trends Immunol 2002; 23: 485491.
  • 4
    Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2002; 2: 346353.
  • 5
    Pratt JR, Harmer AW, Levin J, Sacks SH. Influence of complement on the allospecific antibody response to a primary vascularized organ graft. Eur J Immunol 1997; 27: 28482853.
  • 6
    Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582587.
  • 7
    Springall T, Sheerin NS, Abe K, Holers VM, Wan H, Sacks SH. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med 2001; 7: 801806.
  • 8
    Weisman HF, Bartow T, Leppo MK et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249: 146151.
  • 9
    Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 1997; 150: 17731784.
  • 10
    Lehmann TG, Koeppel TA, Munch S et al. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia. Microvasc Res 2001; 62: 284292.
  • 11
    Zhou W, Farrar CA, Abe K et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105: 13631371.
  • 12
    Baldwin WM III, Larsen CP, Fairchild RL. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2001; 14: 369376.
  • 13
    Weiser MR, Williams JP, Moore FD Jr et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996; 183: 23432348.
  • 14
    Zhao H, Montalto MC, Pfeiffer KJ, Hao L, Stahl GL. Murine model of gastrointestinal ischemia associated with complement-dependent injury. J Appl Physiol 2002; 93: 338345.
  • 15
    Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int 1993; 43: 11601178.
  • 16
    De Vries B, Kohl J, Leclercq WK et al. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 2003; 170: 38833889.
  • 17
    Sacks SH, Zhou W, Pani A, Campbell RD, Martin J. Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 1993; 79: 348354.
  • 18
    Hong Y, Zhou W, Li K, Sacks SH. Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int 2002; 62: 12911300.
  • 19
    Sheerin NS, Zhou W, Adler S, Sacks SH. TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells. Kidney Int 1997; 51: 703710.
  • 20
    Pratt JR, Abe K, Miyazaki M, Zhou W, Sacks SH. In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol 2000; 157: 825831.
  • 21
    Cosio FG, Sedmak DD, Mahan JD, Nahman NS Jr. Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int 1989; 36: 100107.
  • 22
    Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 26822690.
  • 23
    Collard CD, Vakeva A, Bukusoglu C et al. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 1997; 96: 326333.
  • 24
    Vakeva A, Meri S. Complement activation and regulator expression after anoxic injury of human endothelial cells. APMIS 1998; 106: 11491156.
  • 25
    Sacks S, Zhou W, Campbell RD, Martin J. C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells. Clin Exp Immunol 1993; 93: 411417.
  • 26
    Andrews PA, Finn JE, Lloyd CM, Zhou W, Mathieson PW, Sacks SH. Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol 1995; 25: 10871093.
  • 27
    Tang S, Zhou W, Sheerin NS, Vaughan RW, Sacks SH. Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol 1999; 162: 43364341.
  • 28
    Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol 2002; 169: 21022110.
  • 29
    Nataf S, Davoust N, Ames RS, Barnum SR. Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 1999; 162: 40184023.
  • 30
    Yaskanin DD, Waxman FJ. Expression of the CR1 receptor on human leukemia-derived CD4+ T cell lines. Cell Immunol 1995; 163: 139147.
  • 31
    Fernandez-Centeno E, De Ojeda G, Rojo JM, Portoles P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J Immunol 2000; 164: 45334542.
  • 32
    Wagner C, Hansch GM, Stegmaier S, Denefleh B, Hug F, Schoels M. The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes activation-dependent up-regulation and regulatory function. Eur J Immunol 2001; 31: 11731180.
  • 33
    Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998; 16: 545568.
  • 34
    Prechl J, Erdei A. Immunomodulatory functions of murine CR1/2. Immunopharmacology 2000; 49: 117124.
  • 35
    Arvieux J, Yssel H, Colomb MG. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 1988; 65: 229235.
  • 36
    Kreisel D, Krupnick AS, Gelman AE et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med 2002; 8: 233239.
  • 37
    Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic ‘ignorance’ of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686688.
  • 38
    Fischer MB, Ma M, Goerg S et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 1996; 157: 549556.
  • 39
    Marsh JE, Farmer CK, Jurcevic S, Wang Y, Carroll MC, Sacks SH. The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 2001; 72: 13101318.
  • 40
    Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996; 271: 348350.
  • 41
    Welch TR, Beischel LS, Witte DP. Differential expression of complement C3 and C4 in the human kidney. J Clin Invest 1993; 92: 14511458.
  • 42
    Finn JE, Li PK, Lai KN, Mathieson PW. Molecular analysis of C3 allotypes in Chinese patients with immunoglobulin A nephropathy. Am J Kidney Dis 1994; 23: 543546.
  • 43
    Finn JE, Zhang L, Agrawal S, Jayne DR, Oliveira DB, Mathieson PW. Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplant 1994; 9: 15641567.
  • 44
    Poznansky MC, Clissold PM, Lachmann PJ. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3. J Immunol 1989; 143: 12541258.
  • 45
    Andrews PA, Finn JE, Mathieson PW, Sacks SH. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts. Transplantation 1995; 60: 13421346.
  • 46
    Gerritsma JS, Gerritsen AF, De Ley M, Van Es LA, Daha MR. Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 1997; 9: 276283.
  • 47
    Behr TM, Feucht HE, Richter K et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999; 18: 904912.
  • 48
    Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 23712380.
  • 49
    Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574582.
  • 50
    Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002; 11: 609618.
  • 51
    Lemercier C, Julen N, Coulpier M et al. Differential modulation by glucocorticoids of alternative complement protein secretion in cells of the monocyte/macrophage lineage. Eur J Immunol 1992; 22: 909915.
  • 52
    Zach TL, Hill LD, Herrman VA, Leuschen MP, Hostetter MK. Effect of glucocorticoids on C3 gene expression by the A549 human pulmonary epithelial cell line. J Immunol 1992; 148: 39643969.
  • 53
    Strunk RC, Tashjian AH Jr, Colten HR. Complement biosynthesis in vitro by rat hepatoma cell strains. J Immunol 1975; 114: 331335.
  • 54
    Smith RA. Targeting anticomplement agents. Biochem Soc Trans 2001; 30: 10371041.
  • 55
    Dong J, Pratt JR, Smith RA, Dodd I, Sacks SH. Strategies for targeting complement inhibitors in ischaemia/reperfusion injury. Mol Immunol 1999; 36: 957963.
  • 56
    Caren LD, Rosenberg LT. Complement in skin grafting in mice. Immunology 1965; 9: 359364.